Israel’s Public Committee for the Expansion of the Health Care Services Basket on Thursday submitted its 2026 recommendations to Health Minister Haim Katz, proposing new drugs and medical technologies worth a total of 650 million shekels (about…
Category: 6. Business
-

DART (SWOG S1609) Phase II Trial: Nivolumab Plus Ipilimumab in Gynecologic Clear Cell Carcinomas
Gynecologic clear cell carcinomas (CCCs) of the ovary, endometrium, and cervix are rare, chemotherapy-resistant, and clinically aggressive. Single-agent PD-1/PD-L1 blockade has generally produced modest response rates, creating a…
Continue Reading
-

CLL/SLL FDA Approves Combination of Acalabrutinib and Venetoclax
On February 19, the U.S. Food and Drug Administration (FDA) approved the Bruton’s tyrosine kinase inhibitor acalabrutinib (Calquence) tablets and capsules in combination with the BCL2 inhibitor venetoclax (Venclexta) for adults with…
Continue Reading
-

Goldman Flags Limited Re-Rating Potential for Sasol Limited (SSL) Amid Oil Volatility
Sasol Limited (NYSE:SSL) is among the 9 Undervalued Chemical Stocks to Buy According to Hedge Funds.
Goldman Flags Limited Re-Rating Potential for Sasol Limited (SSL) Amid Oil Volatility Sasol Limited (NYSE:SSL) is one of the best…
Continue Reading
-

I’ve driven the cheapest Tesla you can buy, and I think it’s the best of the lot
Keeping up with Tesla’s latest lineup has been tricky over the past few months, because it’s introduced a few new models and then changed their names a few times. The new Model 3 Standard was introduced late last year as the new entry-level…
Continue Reading
-

Brighter UK economy gives Reeves a springboard for March statement | Economic growth (GDP)
The economic backdrop to Rachel Reeves’s upcoming spring statement appeared to brighten on Friday after a trio of reports painted a better-than-expected picture of the UK economy.
Record monthly public finances, a surge in retail spending and…
Continue Reading
-
Giredestrant Plus Everolimus Under FDA Review for ESR1-Mutated, ER+ Advanced Breast Cancer – OncLive
- Giredestrant Plus Everolimus Under FDA Review for ESR1-Mutated, ER+ Advanced Breast Cancer OncLive
- Roche granted FDA review for breast cancer drug (RHHBY) Seeking Alpha
- FDA Accepts New Drug Application for Genentech’s Giredestrant in…
Continue Reading
-
Capital Markets & Governance Insights – February 2026 – Ropes & Gray LLP
- Capital Markets & Governance Insights – February 2026 Ropes & Gray LLP
- The 2026 Director’s Agenda: A Review of Risks and Opportunities for Corporate Directors Akin
- Protecting Property, Not Regulating Markets: Why Reining In Proxy Advisors Is…
Continue Reading
-

Vestas increases offshore momentum in Europe with 1.38 GW offshore order in the United Kingdom
Press Release:
News release from Vestas Northen and Central…
Continue Reading
-

Your Taxes: Mortgage blues and what to do about them
There are reports that some people are planning to stop repaying home mortgages. This apparently would be in protest over economic sanctions against IDF draft dodgers. The sudden loss of cash in the Israeli economy may cause a degree of chaos. Is…
Continue Reading
